H.R. 2410 · 115th Congress
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 115th Congress ended.
D
DavisSponsor2 cosponsors · 1 D, 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced May 11, 2017
- House Passed Feb 26, 2018
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
What it does: CRS summary · Passed House without amendment · Feb 26, 2018
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.
(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
Latest action (Feb 27, 2018): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: House · Introduced: May 11, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced May 11, 2017
- House Passed Feb 26, 2018
No recorded floor vote found.